Safety and Efficacy ATYR1923, a Novel Immunomodulator for Pulmonary Sarcoidosis: Results of a Phase 1b/2a Randomized Placebo-Controlled Trial

Peter H. S. Sporn, R.P. Baughman, Joseph B. Barney et al.|Unknown|2022

Cited by 1